Select Page

Immunify.Life is a transformative and self-funding  healthcare ecosystem secured by blockchain. Its primary use and mission is to use the latest in blockchain technology to improve the health and well being of those in need .The system will  empower individuals to take ownership of their health care data and benefit from its utilisation . This work is strongly aligned to the WHO Sustainable Development Goal 3 “Ensuring healthy lives and promoting well-being at all ages.”

 Immunify.Life is collaborating with Masinde Muliro University of Science and Technology (MMUST)  .with the major goal
to undertake clinical research in Kenya for the purposes of improving patient outcomes and strengthening health
system performance. 

The first major project of this collaboration is a ground breaking study in HIV/AIDS in collaboration with international
NGO AMPATH and academics from Cambridge University . It will investigate the effectiveness of incentives and paper-less tracking systems on HIV treatment adherence and treatment outcomes in low socio-economic settings in Kenya, in particular in Kakamega County in Western Kenya. The study , the first of its type anywhere in the world  has been
funded by the sale of Immunify. life tokens (IMM)

According to UNAIDS, 2020. Kenya  has the third largest HIV community of people living with  HIV globally  (about 1.5 million people) Around  4.5%  of the adult population is affected .There are 21,000 HIV related deaths  each year in Kenya due to the fact that  30% of adults and 40 % children  do not comply to the effective  treatment that is readily  available
to patients.

The  HIV treatment outcomes study examines the impact of providing Crypto currency reward to improve patient compliance to medication ,  ultimately empowering patients, communities . Improving health outcomes and financial
well being of particpants.

The main objective of the study is to investigate the effectiveness of incentives and paper- less tracking systems on
HIV treatment outcomes in low socio-economic settings in Kakamega County, Western Kenya. The 600 patient  study
has receive national regulatory approval and on line training  of healthcare workers has been completed .

This ground breaking study  has been initiated and patient  recruitment will commence in  mid June The study will contribute to the future Strategic Direction of  HIV  management in Kenya, thereby improving health outcomes and wellness of all people living with HIV, through a tracking mechanism for referrals, improve on access to and equal distribution of services and human resources so as to avoid loss in the cascade of care, increased advocacy on anti-retroviral treatment (ART) uptake and adherence and scale up interventions to improve quality of care and improve
health outcomes.